Hideki Uryu¹, Yuko Mishima¹, Masahiro Yokoyama¹, Noriko Nishimura¹, Yoshiharu Kusano¹, Norihito Inoue¹, Anna Nishihara¹, Takanori Fukuta¹, Yuko Shirouchi¹, Naoko Tsuyama², Kengo Takeuchi^2,3, Yasuhito Terui¹ (1.Hematology Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Division of Pathology, The Cancer Institute of JFCR, Tokyo, Japan, 3.Pathology Project for Molecular Targets, The Cancer Institute, Tokyo, Japan)

Naoko Ida, Miyuki Okura, Naoko Hosono, Takahiro Yamauchi (Department of Hematology and Oncology, University of Fukui, Fukui, Japan)

Iwaki Noriko¹, Tatsuya Imi¹, Kohei Hosokawa¹, Hiroyuki Takamatsu¹, Ken Ishiyama¹, Hirohito Yamazaki¹, Shinji Nakao¹, Ryoichi Murata² (1.Department of Hematology, Kanazawa University, Kanazawa, Japan, 2.Department of Hematology, KEIJU Kanazawa Medical Center, Kanazawa, Japan)

Minako Tsutsumi, Takafumi Nakao, Yosuke Nakaya, Masahiro Yoshida, Takuro Yoshimura, Yoshiki Hayashi, Takeshi Inoue, Takahisa Yamane (Osaka City General Hospital, Osaka, Japan)

Jun Nagai, Shinichi Ito, Satomi Matsuoka, Yutaka Tsutsumi (Department of Hematology, Hakodate Municipal Hospital)

Yoshiaki Marumo¹, Shigeru Kusumoto², Takeshi Yanagi³, Fumiya Baba³, Fumiko Mori¹, Shinsuke Iida², Atsushi Inagaki¹ (1.Dept. of Hematol and Oncol., Nagoya City West Medical Center, 2.Dept. of Hematol and Oncol., Nagoya City Univ., Nagoya, Japan, 3.Department of Radiotherapy, Nagoya City West Medical Center)